Qlaris Bio, Inc., a clinical-stage biotechnology company focused on developing first-in-class therapies for glaucoma, today announced the appointment of Robert Warner to its board of directors. Mr.

Nikki Bahan told Newsweek she was sent for a CT scan, which showed multiple blood clots in her right lung.

Researchers are uncovering how disrupted glutamatergic synapses drive diverse forms of intellectual disability, revealing new paths toward targeted treatments.

Age-adjusted D-dimer cutoffs can safely rule out deep vein thrombosis (DVT) in many suspected cases, according to the ADJUST-DVT trial. For patients ages 50 and older with a nonhigh or unlikely ...

A prospective validation study found that age-adjusted D-dimer thresholds can safely rule out lower extremity DVT for more people with low to intermediate suspicion in the first place. The ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-DIMER-PA, the company’s investigational RNA interference (RNAi ...

Researchers have found a potential link between vitamin D deficiency and a higher rate of hospitalization for respiratory ...

Not getting enough vitamin D can weaken bones, teeth, and muscles by interfering with calcium absorption. Lack of the vitamin ...

Scientists are still untangling why the nutrient gap persists—and what it reveals about how women’s health is studied and treated.

Vitamin D supplements are generally in your system after 4 to 12 weeks. Learn more about the importance of consistent supplementation to sustain results.

Medically reviewed by Jamie Johnson, RDN Key Takeaways Too much vitamin D can lead to harmful health effects, including high ...

A daily vitamin D supplement can support bone strength, muscle function, and balance—especially in people who are vitamin D ...